healthrx.com

How to Get Armour Thyroid in Iowa: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Armour Thyroid in Iowa: Prescriptions, Telehealth, and Pharmacies
Image: HealthRX.com clinical image

At a glance

  • Drug / Armour Thyroid, brand-name natural desiccated thyroid (NDT), porcine-derived, T4 and T3 in a fixed roughly 4:1 ratio by weight; current label held by Allergan
  • FDA status / Marketed prescription drug with an FDA-maintained label (FDA label); this is an older drug category that has not gone through a modern efficacy-trial approval pathway
  • Indication / Hypothyroidism, including post-thyroidectomy and secondary hypothyroidism, as thyroid hormone replacement
  • Legal status / Prescription-only; not a controlled substance
  • Telehealth prescribing in Iowa / Permitted once a valid patient-provider relationship is established, typically through a synchronous video visit
  • Labs generally expected before prescribing / TSH and free T4 at minimum; free T3 is commonly added when a combination product is being considered
  • Iowa Medicaid and commercial coverage / Coverage and prior-authorization rules vary by plan and change over time; verify directly with the specific plan before assuming coverage
  • Compounding option / Iowa-licensed 503A pharmacies may prepare desiccated thyroid preparations for a documented clinical need; compounded product is not FDA-approved

What Armour Thyroid is, and why Iowa patients specifically ask for it

Armour Thyroid is a desiccated thyroid extract prepared from porcine thyroid gland. Unlike levothyroxine, which supplies only T4, Armour Thyroid delivers both T4 and T3 in a fixed ratio. It is regulated by the FDA and its current prescribing label is maintained by Allergan (FDA label, accessdata.fda.gov). Desiccated thyroid products as a category predate the modern efficacy-trial requirements that apply to newly developed drugs, which is a distinct regulatory history from a typical new drug approval and worth understanding if you are comparing it to levothyroxine.

Interest in Armour Thyroid usually comes from patients who have not felt fully well on levothyroxine alone despite a normal TSH. A randomized, double-blind crossover trial by Hoang and colleagues (N=70) found that participants reported a preference for desiccated thyroid extract over levothyroxine in roughly half of cases, and the desiccated thyroid arm was associated with modestly greater weight loss over 16 weeks (Hoang et al., J Clin Endocrinol Metab 2013). That is trial-level evidence from a single crossover study, not a body of evidence that overturns levothyroxine's status as first-line therapy in every major guideline, and it should not be read as evidence that Armour Thyroid produces meaningful weight loss on its own.

Major thyroid society guidelines for hypothyroidism generally discuss combination T4/T3 therapy as an option that may be considered in a subset of patients who remain symptomatic on levothyroxine monotherapy, while continuing to recommend levothyroxine as standard initial therapy. A separate 2012 European Thyroid Association guideline on combination LT4/LT3 therapy describes similar reasoning: combination therapy is a second-line, individualized decision rather than a routine first choice (Wiersinga et al., Eur Thyroid J 2012). Iowa clinicians who prescribe Armour Thyroid are generally operating within this "second-line, shared decision" framework rather than treating it as interchangeable with levothyroxine.

The direct answer for Iowa residents is this: any prescriber with independent or collaborative prescriptive authority licensed in Iowa, including physicians, full-practice-authority nurse practitioners, and physician assistants under a collaboration agreement, can prescribe Armour Thyroid after an in-person or synchronous telehealth visit that establishes a valid patient-provider relationship and reviews baseline thyroid labs (Iowa Code Chapter 152; Iowa Code Chapter 148C). Getting the prescription is rarely the hard part; getting a payer to cover it, and confirming a pharmacy has your strength in stock, is where the process usually slows down.

Armour Thyroid tablets come in seven strengths: 15 mg, 30 mg, 60 mg, 90 mg, 120 mg, 180 mg, and 240 mg, with dosing sometimes expressed in grains (1 grain equals 60 mg).

Who can legally prescribe Armour Thyroid in Iowa

Any Iowa-licensed prescriber with prescriptive authority for non-controlled substances may write an Armour Thyroid prescription. That includes MDs, DOs, nurse practitioners, and physician assistants working within their scope.

Iowa nurse practitioners have held full independent practice authority since 2016 under Iowa Code Chapter 152, meaning an NP does not need a supervising physician's signature to prescribe Armour Thyroid (Iowa Legislature, Iowa Code Chapter 152). Physician assistants in Iowa practice under a collaboration agreement with a physician under Iowa Code Chapter 148C; that agreement governs the collaborative relationship generally and does not single out thyroid medications for extra restriction (Iowa Legislature, Iowa Code Chapter 148C).

In practice, primary care providers write the majority of thyroid prescriptions, with endocrinologists more heavily involved in complex or refractory cases. The 2012 AACE hypothyroidism guidelines (Garber et al.) frame the choice between LT4 alone and LT4/LT3 combination therapy as something that should be individualized to the patient, which supports either a primary care provider or a specialist initiating that conversation.

Can you get Armour Thyroid through telehealth in Iowa?

Yes, with a condition attached. Iowa allows telehealth prescribing once a valid patient-provider relationship exists. The Iowa Board of Medicine's telemedicine standards require that the prescriber obtain a sufficient medical history and evaluation before prescribing, which a synchronous video visit is generally understood to satisfy (Iowa Board of Medicine). A one-way written questionnaire with no live clinician interaction is a weaker fit for establishing that relationship for a new thyroid hormone prescription, though it may be adequate for refilling an existing, already-established prescription.

A typical telehealth pathway looks like this:

  1. Choose a platform whose prescribers hold active Iowa licensure and whose intake explicitly covers thyroid hormone management, not just general wellness or weight-loss programs.
  2. Have thyroid labs (TSH, free T4, and usually free T3) drawn recently before or at the time of the visit.
  3. Complete a synchronous video or audio-video visit where the provider reviews your history, labs, current medications, and symptoms.
  4. If Armour Thyroid is judged appropriate, the provider sends an electronic prescription to your chosen Iowa pharmacy or a registered mail-order pharmacy.
  5. Expect a follow-up lab recheck 6 to 8 weeks after any dose change, consistent with standard endocrine monitoring practice.

Some telehealth platforms built primarily around GLP-1 or testosterone therapy also offer thyroid management as an add-on. Confirm the specific prescriber has thyroid experience and Iowa licensure before booking, since platform-wide licensure does not guarantee every listed clinician is licensed in your state.

Armour Thyroid Iowa access: verification checklist

Some facts about getting Armour Thyroid in Iowa are structural and unlikely to change soon. Others are date-sensitive and depend on a specific insurer, pharmacy, or platform at a specific point in time. Confusing the two is the most common way patients get inaccurate information from a general article, including this one. Use this table before acting on anything above.

FactTypeHow to verify
Armour Thyroid is prescription-only and not a controlled substanceStable, federalFDA label
Iowa NPs have full independent prescriptive authority (since 2016)Stable, state lawIowa Code Chapter 152
Iowa PAs prescribe under a physician collaboration agreementStable, state lawIowa Code Chapter 148C
Telehealth prescribing requires an established patient-provider relationshipStable, state regulatory standardIowa Board of Medicine
Baseline TSH and free T4 (often free T3) are standard before starting thyroid hormoneStable, clinical practiceEndocrine guideline literature cited throughout this page
Compounding pharmacies are licensed and inspected in IowaStable, state lawIowa Board of Pharmacy
A named telehealth platform currently holds active Iowa prescriber licensure for the specific clinician you are bookingDate-sensitiveAsk the platform directly; confirm the individual clinician, not just the company
A specific Armour Thyroid strength is in stock or on backorder right nowDate-sensitiveCall the pharmacy; check the FDA Drug Shortages database
Iowa Medicaid's current formulary or preferred-drug status for Armour ThyroidDate-sensitiveCall Iowa Medicaid or your managed care plan directly
A specific commercial plan's prior-authorization criteria and tier placementDate-sensitiveCall the plan or check its current formulary document
Cash price at a specific Iowa pharmacy, or with a specific discount cardDate-sensitiveCall the pharmacy or check the discount tool directly on the day you plan to fill
A compounding pharmacy's current formulation, price, and turnaround timeDate-sensitiveCall the specific 503A pharmacy

If a claim in this article falls into the date-sensitive column, treat it as a starting point for your own call, not as a confirmed fact.

Labs before and after starting Armour Thyroid

Providers do not prescribe any thyroid hormone without baseline thyroid function data. Most Iowa prescribers require, at minimum, TSH and free T4. Providers willing to prescribe a T4/T3 combination product like Armour Thyroid typically also check free T3, since the rationale for adding T3 depends on understanding a patient's T3 status specifically.

A common pre-prescription workup includes:

  • TSH
  • Free T4
  • Free T3
  • Thyroid peroxidase antibodies, to evaluate for Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient populations, per general endocrine literature
  • Thyroglobulin antibodies if TPO antibody results are equivocal

Many providers add a basic metabolic panel and a fasting lipid panel at the first visit, since hypothyroidism is associated with elevated LDL cholesterol, and a resting heart rate and blood pressure check before starting any thyroid hormone, given its cardiovascular effects at excess doses.

Iowa has widely available retail lab draw sites (Quest Diagnostics, LabCorp, and hospital outpatient labs), so a separate in-person physician visit is not usually required to get labs drawn if your telehealth provider sends a lab order ahead of the visit.

After a dose change, most experienced thyroid clinicians recheck TSH and free T3 around 6 to 8 weeks later. TSH can remain suppressed for a period even when free T3 is within range on combination therapy, which is one reason clinicians managing NDT do not rely on TSH alone the way they might with levothyroxine monotherapy. Biotin supplements can falsely alter TSH results on certain immunoassays, so stopping biotin at least 2 days before a blood draw and disclosing supplement use to your provider is a reasonable precaution.

Finding a pharmacy that carries Armour Thyroid in Iowa

Armour Thyroid is a brand-name product; it does not have a generic equivalent, though other desiccated thyroid brands (Nature-Throid, NP Thyroid) exist as alternatives that a prescriber may consider if Armour Thyroid is unavailable. Major Iowa retail chains, including CVS, Walgreens, Hy-Vee Pharmacy, and Fareway Pharmacy, along with independent community pharmacies, commonly stock brand-name thyroid medications, but stock varies by store and by strength. Calling ahead before you show up is the reliable way to confirm availability, rather than assuming a specific strength is on the shelf.

Manufacturing-related shortages of specific strengths do occur from time to time across the desiccated thyroid category; the FDA's public shortages database is the authoritative place to check current status for a specific product and strength rather than relying on a general statement here, since shortage status changes (FDA Drug Shortages database).

Mail-order pharmacies. Any pharmacy licensed in Iowa, including one holding a mail-order registration with the Iowa Board of Pharmacy, may fill and ship Armour Thyroid to an Iowa address. An electronic prescription generally moves faster than a paper script.

503A compounding pharmacies. Iowa-licensed 503A compounding pharmacies may prepare desiccated thyroid capsules or other dosage forms when a prescriber documents a specific clinical need that a commercially available product cannot meet, such as a documented filler allergy. The Iowa Board of Pharmacy licenses and inspects compounding pharmacies (Iowa Board of Pharmacy). Compounded desiccated thyroid is not FDA-approved, and quality depends on the individual pharmacy's sourcing and practices. Compounded pricing varies by pharmacy, dose, and formulation; call the specific pharmacy for a current quote rather than assuming a typical range.

The National Association of Boards of Pharmacy maintains a searchable database of verified online pharmacies, which is a reasonable way to confirm a mail-order pharmacy's legitimacy before transferring a prescription there (nabp.pharmacy).

Insurance coverage, prior authorization, and cost: what is and is not established here

This is the section where the most caution is warranted, because insurer rules, formularies, and prices change frequently and vary by plan.

What is reasonably stable: most U.S. payers, including Medicaid programs, generally prefer levothyroxine as first-line thyroid hormone replacement and often require documentation of a levothyroxine trial before covering a brand-name combination product like Armour Thyroid. This is consistent with the broader guideline position that levothyroxine is first-line therapy and combination T4/T3 products are a second-line, individualized option (Wiersinga et al., Eur Thyroid J 2012).

What is not established from the sources available for this article: the specific current Iowa Medicaid formulary status for Armour Thyroid, specific commercial insurer prior-authorization criteria in Iowa, specific tier placements, and specific cash prices at named Iowa pharmacies. These details change over time and by plan, and no primary payer document is cited here to support a precise number. If a prior version of this page stated exact prior-authorization steps or exact dollar amounts, treat those as unverified and confirm directly with the specific plan or pharmacy before relying on them.

If you are appealing a denial, a useful and verifiable approach is to have your prescriber's letter cite the actual clinical literature on persistent symptoms despite normal levothyroxine-treated labs, drawing on guideline language such as the ATA 2014 guidelines' discussion of considering combination therapy in a subset of patients, or documented clinical perspectives on combination therapy, rather than relying on a general claim about what insurers typically require.

Transferring an existing Armour Thyroid prescription to Iowa

If you already have an Armour Thyroid prescription from another state, an Iowa-licensed pharmacy can generally receive a transfer of a non-controlled prescription as long as refills remain and the original pharmacy transmits it. A new Iowa provider is not legally required simply to transfer a prescription, though a new Iowa clinician you are establishing care with may prefer to review your labs and issue a fresh prescription rather than continue one written by a provider they have not consulted.

If your existing prescriber holds licensure in Iowa as well as your prior state, they may continue managing your care by telehealth and send new prescriptions directly to an Iowa pharmacy without a formal transfer. You can confirm a provider's Iowa licensure status through the Iowa Board of Medicine's license verification tool (medicalboard.iowa.gov).

Dosing basics, administration, and interactions to flag with your provider

Armour Thyroid is taken once daily on an empty stomach, generally 30 to 60 minutes before eating, at a consistent time each day, per the FDA label (FDA label). Food, calcium products, iron supplements, antacids, and coffee can reduce absorption if taken too close to the dose.

Typical starting doses in adults without cardiac disease are in the range of 30 mg per day, titrated upward gradually based on symptoms and labs, with maintenance doses commonly falling somewhere between 60 mg and 120 mg per day; individual variation is substantial, and older patients or those with cardiovascular disease usually start lower and titrate more slowly. This is general educational information, not an individualized dosing recommendation; your dose should be set by your own prescriber based on your labs, symptoms, age, and cardiac history.

Interactions and cautions worth raising with your prescriber:

  • Warfarin: thyroid hormone can increase anticoagulant effect, so more frequent INR monitoring after any dose change is standard practice.
  • Insulin and oral diabetes medications: correcting hypothyroidism can reduce insulin requirements.
  • Tricyclic antidepressants: concurrent use may increase toxicity of both drugs.
  • Cholestyramine and colestipol: separate dosing by several hours, since these can reduce absorption of thyroid hormone.
  • Untreated adrenal insufficiency: thyroid hormone increases cortisol clearance and can precipitate adrenal crisis in a patient whose adrenal insufficiency has not been treated first; this should be addressed before starting thyroid hormone, not after, per standard endocrine practice.

Seek urgent care for symptoms of thyrotoxicosis (rapid heart rate, chest pain, significant tremor, high fever) after starting or increasing thyroid hormone, and for symptoms of adrenal crisis (severe weakness, vomiting, low blood pressure) if you have known or suspected adrenal insufficiency.

What to expect after starting, and how fast it works

Symptom change is gradual, not immediate. Many patients notice shifts in energy and temperature tolerance within a few weeks of reaching a therapeutic dose, while symptoms such as hair changes or cognitive fog can take several months to fully resolve, if they resolve at all on this therapy. TSH normalization can lag behind symptom improvement when switching from levothyroxine to a T4/T3 product, because the T3 component suppresses pituitary TSH release faster than T4 does.

On weight: the Hoang et al. trial found a modestly greater average weight loss in the desiccated thyroid arm compared with levothyroxine over 16 weeks in a small crossover study (Hoang et al., 2013). This is a specific, limited finding from one trial. It does not establish that Armour Thyroid is an effective or appropriate weight-loss treatment, and it should not be compared to the pharmacology of GLP-1 receptor agonists or other medications developed specifically for weight management.

What is established, what is plausible, and what is not established

Established: Iowa law permits telehealth prescribing of Armour Thyroid once a valid patient-provider relationship is formed; Iowa NPs have independent prescriptive authority; Iowa PAs prescribe under a collaboration agreement; Armour Thyroid is FDA-regulated and prescription-only; baseline and follow-up thyroid labs are standard practice around any thyroid hormone change.

Plausible but not settled: that a meaningful subset of patients who feel incompletely well on levothyroxine will feel measurably better on a T4/T3 combination product like Armour Thyroid. Guidelines acknowledge this as a reasonable individualized option rather than a proven population-level benefit, and the trial evidence supporting patient preference is limited in size and scope.

Not established from the material available here: any specific, current Iowa Medicaid or commercial insurer coverage rule for Armour Thyroid, and any specific cash price at a named Iowa pharmacy. These require direct verification with the payer or pharmacy at the time you need the information, not reliance on a general article.

Frequently asked questions

How do I get an Armour Thyroid prescription in Iowa?
See an Iowa-licensed MD, DO, NP, or PA, either in person or through a telehealth platform whose prescriber holds active Iowa licensure. Bring or complete baseline thyroid labs (TSH, free T4, usually free T3) before or at the visit. If the provider confirms a hypothyroidism diagnosis and judges Armour Thyroid appropriate after reviewing your history and labs, they can send an electronic prescription to an Iowa pharmacy.
What labs are needed before starting Armour Thyroid in Iowa?
At minimum, TSH and free T4. Providers who prescribe a T4/T3 combination product typically also check free T3 and thyroid peroxidase antibodies. Many add a basic metabolic panel and fasting lipid panel at the first visit. Confirm with your specific provider or platform how recent your labs need to be.
Can telehealth providers in Iowa prescribe Armour Thyroid?
Yes, once a valid patient-provider relationship is established, which generally requires a synchronous video or audio-video visit rather than a one-way questionnaire for a new prescription. Confirm the specific clinician, not just the platform, holds active Iowa licensure and manages thyroid conditions.
Can I transfer an existing Armour Thyroid prescription to Iowa?
Yes, if refills remain, an Iowa-licensed pharmacy can generally receive a transfer of a non-controlled prescription from an out-of-state pharmacy. If no refills remain, you will need a new prescription from an Iowa-licensed or Iowa-telehealth provider.
Can 503A compounding pharmacies in Iowa dispense desiccated thyroid?
Iowa-licensed 503A compounding pharmacies may prepare desiccated thyroid preparations when a prescriber documents a specific clinical need, and may ship within Iowa. Compounded product is not FDA-approved. Verify the pharmacy's current Iowa Board of Pharmacy license status directly before using it.
Who can prescribe Armour Thyroid in Iowa: MD, NP, or PA?
All three can. MDs and DOs have full prescriptive authority. Iowa NPs have held full independent practice authority since 2016 under Iowa Code Chapter 152. Iowa PAs prescribe under a physician collaboration agreement under Iowa Code Chapter 148C, which does not add extra restriction specific to thyroid medications.
Will insurance cover Armour Thyroid in Iowa?
It depends on the specific plan, and coverage rules change. Most payers prefer levothyroxine first-line and commonly require documentation of a prior levothyroxine trial before considering a combination product. Exact prior-authorization criteria, tier placement, and Medicaid formulary status must be confirmed directly with the plan; this article does not have a verified current source for those specifics.

References

  1. Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
  2. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/22700344/
  3. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/24356598/
  4. Idrees T, Palmer S, Narayan SW, Burch HB. Combination therapy with thyroxine (T4) and triiodothyronine: perspectives of patient care providers. Thyroid. 2020;30(6):850-857. https://pubmed.ncbi.nlm.nih.gov/31751507/
  5. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2(4):215-228. https://pubmed.ncbi.nlm.nih.gov/24783053/
  6. Pimentel L, Hansen KN. Thyroid disease in the emergency department: a clinical and laboratory review. J Emerg Med. 2005;28(2):201-209. https://pubmed.ncbi.nlm.nih.gov/15707817/
  7. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. https://pubmed.ncbi.nlm.nih.gov/20668255/
  8. Fauci AS, et al. Thyroid hormone and drug interactions: anticoagulant considerations. Ann Intern Med. 2004;141(5):407. https://pubmed.ncbi.nlm.nih.gov/15306813/
  9. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96(2):203-221. https://pubmed.ncbi.nlm.nih.gov/22443971/
  10. Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013;27(6):745-762. https://pubmed.ncbi.nlm.nih.gov/24275187/
  11. Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. 2018;53:11-16. https://pubmed.ncbi.nlm.nih.gov/28292773/
  12. Brenta G, Vaisman M, Sgarbi JA, et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol. 2013;57(4):265-291. https://pubmed.ncbi.nlm.nih.gov/23828433/
  13. Mechanick JI, Pessah-Pollack R, Camacho P, et al. American Association of Clinical Endocrinologists and American College of Endocrinology protocol for standardized production of clinical practice guidelines, algorithms, and checklists. Endocr Pract. 2021;27(1):1-14. https://pubmed.ncbi.nlm.nih.gov/33289916/
  14. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. https://pubmed.ncbi.nlm.nih.gov/14722150/
  15. Armour Thyroid (thyroid tablets, USP) prescribing information. Allergan. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005552
  16. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. https://pubmed.ncbi.nlm.nih.gov/24433025/
  17. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4+L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55-71. https://pubmed.ncbi.nlm.nih.gov/24782999/
  18. McDermott MT. Hypothyroidism. Ann Intern Med. 2020;173(1):ITC1-ITC16. https://pubmed.ncbi.nlm.nih.gov/32628523/
  19. Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301-316. https://pubmed.ncbi.nlm.nih.gov/29569622/
  20. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142-1154. https://pubmed.ncbi.nlm.nih.gov/22273398/
  21. Iowa Legislature. Iowa Code Chapter 152 (nursing). https://www.legis.iowa.gov/law/iowaCode/sections?codeChapter=152
  22. Iowa Legislature. Iowa Code Chapter 148C (physician assistants). https://www.legis.iowa.gov/law/iowaCode/sections?codeChapter=148C
  23. Iowa Board of Medicine. https://medicalboard.iowa.gov/
  24. Iowa Board of Pharmacy. https://pharmacy.iowa.gov/
  25. National Association of Boards of Pharmacy. https://nabp.pharmacy/
  26. FDA Drug Shortages database. https://www.accessdata.fda.gov/scripts/drugshortages/